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Abstract
The differentiation of self-renewing progenitor cells requires not only the regulation of line-
age- and developmental stage–specific genes but also the coordinated adaptation of house-
keeping functions from a metabolically active, proliferative state toward quiescence. How
metabolic and cell-cycle states are coordinated with the regulation of cell type–specific
genes is an important question, because dissociation between differentiation, cell cycle, and
metabolic states is a hallmark of cancer. Here, we use a model system to systematically
identify key transcriptional regulators of Ikaros-dependent B cell–progenitor differentiation.
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We find that the coordinated regulation of housekeeping functions and tissue-specific gene
expression requires a feedforward circuit whereby Ikaros down-regulates the expression of
Myc. Our findings show how coordination between differentiation and housekeeping states
can be achieved by interconnected regulators. Similar principles likely coordinate differenti-
ation and housekeeping functions during progenitor cell differentiation in other cell lineages.
Author summary
The human body is made from billions of cells comprizing many specialized cell types. All
of these cells ultimately come from a single fertilized oocyte in a process that has two key
features: proliferation, which expands cell numbers, and differentiation, which diversifies
cell types. Here, we have examined the transition from proliferation to differentiation
using B lymphocytes as an example. We find that the transition from proliferation to dif-
ferentiation involves changes in the expression of genes, which can be categorized into
cell-type–specific genes and broadly expressed “housekeeping” genes. The expression of
many housekeeping genes is controlled by the gene regulatory factor Myc, whereas the
expression of many B lymphocyte–specific genes is controlled by the Ikaros family of gene
regulatory proteins. Myc is repressed by Ikaros, which means that changes in housekeep-
ing and tissue-specific gene expression are coordinated during the transition from prolif-
eration to differentiation.
Introduction
Cell proliferation, metabolic state, and differentiation are linked: proliferating progenitor cells
exit the cell cycle and adjust their metabolism as they differentiate [1–3]. Mechanistically, this
coordination is thought to involve mutual antagonism between cyclin-dependent kinases that
promote cell-cycle entry and transcription factors that induce tissue-specific gene expression
[1,2].
A detailed inventory of differentiation stages is available for mammalian haematopoiesis. In
B cell differentiation, discrete stages are defined by CD markers [4], gene expression profiles [5]
(www.immgen.org), transcription factor binding [6–8], and cell-cycle states [9–11]. A critical
step is the transition of proliferating B cell progenitors towards cell-cycle arrest and differentia-
tion. We refer to proliferating B cell progenitors as Fr.C following Hardy’s nomenclature [4];
this stage is also known as the pro-B, pre-B1, or large pre–B cell stage (Fig 1A). We refer to qui-
escent, differentiating B cell progenitors as Fr.D following Hardy’s nomenclature [4]; this stage
is also known as the pre-B, pre-B2, or small pre–B cell stage (Fig 1A). Transcriptional regulators
of the Ikaros family of zinc finger proteins are up-regulated at this transition [12] and are
required for B cell progenitor differentiation in vivo [13–15]. IKZF1, the gene encoding Ikaros,
is recurrently mutated in human B cell progenitor acute lymphoblastic leukemias (B-ALLs)
with translocations between the IGH locus and the ABL1 proto-oncogene (BCR-ABL1) [16,17].
Here, we employ an inducible system in a B cell progenitor line that models the transition
from B cell progenitor proliferation toward cell-cycle arrest and differentiation upon the regu-
lated delivery of the transcription factor Ikaros from the cytoplasm into the nucleus [7,18].
The availability of this in vitro model, combined with access to primary B cell progenitors for
validation experiments, makes B cell progenitor differentiation an attractive system to study
progenitor differentiation and the mechanisms that link differentiation with changes in cell
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cycle and metabolism. To understand the regulatory control of B cell progenitor differentia-
tion, we developed an algorithm that examines the temporal correlation between the expres-
sion of transcription factors and their target genes over the course of progenitor differentiation
and scores the relative contribution of different transcription factors This approach, which is
transferable to other cell-state transitions, highlighted that the Ikaros targets Foxo1 and Myc as
high-scoring transcription factors. Perturbation experiments showed that the transcriptional
repression of Myc was critical for the coordinated regulation of lineage-specific, cell-cycle, and
metabolic genes. Ikaros-mediated repression of Myc connects B cell differentiation to cell-
cycle exit and metabolic adaptation. Similar principles may coordinate differentiation and
housekeeping functions during progenitor differentiation in other cell lineages.
Results
Temporal dissection of gene expression changes during B cell progenitor
differentiation
We controlled the dosage of nuclear Ikaros-ERt2 with temporal precision by the addition of
4-hydroxy-tamoxifen (4-OHT) in the pre–B cell line B3 [7,18]. This model is designed to
approximate the B cell linker (BLNK)-dependent increase of Ikzf3 expression in primary
B cell progenitors in response to pre-B cell receptor signaling [12], and the nuclear transloca-
tion of Ikaros recapitulates the majority of gene expression changes that distinguishes prolifer-
ating (Fr.C) from differentiating (Fr.D) B cell progenitors in vivo [7,18]. We performed time-
resolved RNA sequencing (RNA-seq) of 4-OHT-treated B3 cells expressing Ikaros-ERt2 or
control vector (Fig 1B) at 6 time points after 4-OHT. We combined pairwise comparison
between time points by limma [19] with time-course analysis by maSigPro [20] to identify
5,865 differentially expressed genes (S1 Table). Pseudotemporal ordering [21] of single cell
RNA-seq (scRNA-seq) data showed an unbranched path over the experimental differentiation
time course (Fig 1C).
Dynamics and validation of the experimental system
Gaussian mixture modeling for model-based clustering [22] resolved up- and down-regulated
genes, subtrends of immediate and delayed regulation, and 2 nonmonotonic up-down–and
down-up–regulated groups (Fig 1D). Functional characterization of these trends by gene set
analysis showed that up-regulated genes were enriched in Janus kinase/signal transducers and
activators of transcription (JAK-STAT) signaling, cell adhesion, and B cell receptor and inter-
leukin signalling, while metabolic functions, RNA metabolism, and ribosome biogenesis were
enriched among down-regulated genes. This analysis indicates a clear distinction between
induced (signaling and cell–cell communication) and repressed (mainly metabolism-related)
processes during B cell progenitor differentiation (Fig 1D).
To ask how well this experimental system models B cell progenitor differentiation in vivo,
we compared dynamic gene expression at each time point with static, developmental stage-
specific gene expression by primary B cell progenitors [5]. Up to 6 h after 4-OHT-induced
nuclear translocation of Ikaros, gene expression correlated positively with the less mature Fr.C
and negatively with the more mature Fr.D states in vivo (Fig 1E). The 12 h time point marked
a tipping point at which the positive correlation with Fr.C and the negative correlation with
Fr.D was lost (Fig 1E). After that, gene expression correlated positively with the more mature
Fr.D and negatively with the less mature Fr.C (Fig 1E). Therefore, gene expression in B3 cells
showed a transition from an Fr.C-like state to an Fr.D-like state within a 24-h time frame. The
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Fig 1. An Ikaros-driven in vitro system captures key features of in vivo B cell progenitor differentiation. (A) Schematic representation of self-renewing (left)
and differentiating (right) B cell progenitors and the nomenclature used to refer to these populations in the literature. (B) Experimental design of Ikaros-induced
B3 cell differentiation. RNA-seq was performed at the indicated time points. The experiment was designed so that sources of variability could be traced to library
preparation and sequencing biases and corrected (see Methods). Effects of 4-OHT were monitored by addition of 4-OHT to control vector cells and found to be
negligible. (C) Pseudotemporal ordering of cells as a function of their scRNA-seq transcriptomes. The pseudotime trajectory is shown in black. (D) Gene set
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experimental system allowed the capture not only of the start and end points but also the
dynamics that occurred between them.
To examine the ability of this model system to pinpoint Ikaros target genes relevant to
human disease, we assembled gene expression profiles of 1,404 B-ALL samples with and with-
out IKZF1 mutations (S1 Fig and associated text). Genes that were differentially expressed
between Fr.C and Fr.D were preferentially deregulated in IKZF1-mutated B-ALL [23,24],
including current and potential therapeutic targets [25–27] and prognostically relevant gene
signatures in B-ALL [17,28] (S1 Fig). There was significant overlap between differential gene
expression in IKZF1-mutated B-ALL and early gene expression changes in B3 cells at 0 to 2 h
after Ikaros induction (Fig 1F, odds ratio = 2.53, adjusted [adj.] P = 0.02 for the 200 top differ-
entially expressed genes). Because early gene expression changes are likely direct, this finding
indicates that our in vitro system identifies gene expression changes in IKZF1-mutated B-ALL
that may result directly from the loss of Ikaros function.
The progression from proliferating to resting stages of pre–B cell
differentiation is marked by “reverse” metabolic reprogramming
To follow up on the down-regulation of genes related to metabolism (Fig 1D), we compared
the expression of glycolysis and tricarboxylic acid (TCA) cycle genes during B3 cell differentia-
tion in vitro (Fig 2A and 2B, left) and B cell progenitor differentiation in vivo (Fig 2A and 2B,
right). Key glycolysis and TCA cycle genes were down-regulated in vitro and in vivo (Fig 2A
and 2B; the transition from Fr.C to Fr.D is indicated with a bracket). Analysis of Ikaros chro-
matin immunoprecipitation sequencing (ChIP-seq) data [7] showed that numerous core meta-
bolic genes were directly bound by Ikaros, as illustrated by the glucose transporter Slc2a1 and
the TCA cycle gene Fh1 (Fig 2C; see figure legend for a list of Ikaros-bound core metabolic
genes).
In extracellular flux assays, nuclear translocation of Ikaros triggered a pronounced reduc-
tion (55%–65%) in extracellular acidification (ECAR) as a measure of lactate production (Fig
2D, left). The oxygen consumption rate (OCR) was reduced by 45%–50% (Fig 2D, right). This
was accompanied by reduced mechanistic target of rapamycin complex 1 (mTORC1) activity,
as read out by phosphorylation of S6 ribosomal protein (S3A Fig) and the transcriptional up-
regulation of autophagy genes (S3B Fig).
To validate these findings, we transduced primary Fr.C-like B cell progenitors with Ikaros
or Ikzf3 (Aiolos) and determined the resulting changes in ECAR and the OCR. Ikaros and Aio-
los reduced the ECAR and the OCR of primary B cell progenitors (Fig 2E).
In the experiments described above, changes in metabolic gene expression and metabolic
activity were induced by the expression of Ikzf1 or Ikzf3. During B cell progenitor differentia-
tion, Ikzf3 expression is initiated by signaling through the pre-B cell receptor via a pathway
that requires BLNK [12]. To determine whether pre-B cell receptor signaling is linked to
analysis of gene expression trends in B3 differentiation. Each box contains the total number of genes and the major functional terms (q< 0.01) for each of 4
expression trends (up-regulated, down-regulated, first up- then down-regulated, and first down- then up-regulated). Up- and down-regulated trends are further
separated into 2 subtrends, constant and delayed. (E) Comparison of the transcriptomes of the B3 in vitro differentiation time course with in vivo B cell
progenitor differentiation stages. The 0 to 6 h time points resemble Fr.C, whereas 18 and 24 h are similar to Fr.D, and the 12 h time point represents a tipping
point. The source of the numerical data underlying this figure is listed in S1 Data. (F) Comparison of genes differentially expressed in IKZF1 mutated human
B-ALL and the B3 differentiation. Numbers denote common genes that are differentially expressed in IKZF1-mutated versus IKZF1 wild-type human B-ALL and
the top 200 genes regulated at the indicated times after Ikaros induction in B3 cells. The color scale indicates the odds ratio for the enrichment of Ikaros-
regulated gene during B3 cell differentiation among differentially expressed genes in human B-ALL with and without IKZF1 mutations. B-ALL, B cell progenitor
acute lymphoblastic leukemia; ERt2; Fr.C, proliferating B cell progenitor; Fr.D, differentiating B cell progenitor; HA, haemagglutinin; JAK-STAT, Janus kinase/
signal transducers and activators of transcription; RNA-seq, RNA sequencing; scRNA-seq, single cell RNA sequencing; TCA, tricarboxylic acid cycle; 4-OHT,
4-hydroxy-tamoxifen.
https://doi.org/10.1371/journal.pbio.2006506.g001
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Fig 2. Progression from proliferating to resting stages of pre–B cell differentiation is marked by metabolic reprogramming. (A) Heat
map of glycolysis gene expression in B3 cells (left) and at consecutive stages of B cell progenitor differentiation in vivo (right). The
transition from Fr.C to Fr.D is marked by a bracket. The source of the numerical data underlying this figure is listed in S1 Data. (B) Heat
map of TCA cycle gene expression in B3 cells (left) and at subsequent stages of B cell progenitor differentiation in vivo (right). The source
of the numerical data underlying this figure is listed in S1 Data. (C) Ikaros ChIP-seq shows that Ikaros targets metabolic genes. The
Feedforward regulation of Myc
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metabolic regulation, we used an experimental system in which BLNK activity can be induci-
bly restored in BLNK-deficient B cells by means of a 4-OHT-inducible BLNK-ERt2 fusion pro-
tein [29]. As expected, restoration of BLNK activity induced Ikzf3 and repressed Igll1, a known
target of Ikzf1 and Ikzf3 during the the Fr.C to Fr.D transition [12,18] (Fig 2F, top). Restoration
of BLNK activity led to the repression of the metabolic genes Slc7a5, Hk2, and Ldha (Fig 2F,
bottom), indicating that pre-B cell receptor signaling controls the expression of metabolic
genes in B cell progenitors.
These data demonstrate altered metabolic gene expression, reduced glycolytic flux, and a
drop in oxygen consumption at the transition of B cell progenitors from proliferation to quies-
cence in vitro and in vivo. This indicates “reverse” metabolic reprogramming towards a less
glycolytic state [30,31]. The expression of B cell genes such as Igll1 and Foxo1 was correlated
with the expression of housekeeping genes, such as Myc, the metabolic gene Hk2, and the cell-
cycle gene Ccnd2, not only at the level of cell populations but also in individual cells (Fig 2G).
We conclude that the regulation of B cell–specific genes is coordinated with the regulation of
housekeeping pathways during B cell progenitor differentiation.
Systematic identification of key transcription factors in B cell progenitor
differentiation
B cell progenitor differentiation is marked by the differential expression of numerous tran-
scription factors. To define the key transcription factors and the regulatory pathways involved
in this process, we first identified all transcription factor genes that showed a significant and
robust (log2 fold change > 1.5) change in expression between consecutive time points. We
considered transcription factors that were differentially expressed (adj. P< 0.01) between Fr.C
and Fr.D in vivo ([5]; www.immgen.org). We included transcription factors that showed up-
down–or down-up–regulation over the in vitro time course, based on the consideration that
genes with nonmonotonic expression may be important for B cell progenitor differentiation
even if they were not differentially expressed between the start and the end of the transition.
This resulted in a total of 23 candidate transcriptional regulators (Fig 3A, Table 1). To evaluate
the potential importance (or “weight”) of transcriptional regulators during cell-state transi-
tions, we developed an approach that numerically integrates the differential expression over
time of transcription factors and their target genes, which we refer to as transition weight
matrix (TWM). For each transcription factor, we identified potential target genes based on
transcription factor ChIP-seq peaks in gene promoters. We then determined the enrichment
of transcription factor binding over differentially expressed genes and multiplied this enrich-
ment with the log2 fold change in transcription factor mRNA expression for each time interval.
The resulting values were summed over the time series to yield a score for transcription factor
expression and target enrichment over time. We next examined to what extent the expression
of each transcription factor correlated with mRNA levels of its target genes in a consistent
fashion over time, which we term “coherence.” Coherence between the expression of each
embryonic stem cell gene Esrrb is a negative control. Other Ikaros-bound core metabolic genes are Dlat, Hk2, Idh3g, Slc2a3, Dlst, Sdhb,
Pgam1, Mdh2, Pfkl, Dld, Pfkp, Sdha, Pcx, Idh1, Fh1, Aco1, Slc2a1, Slc2a5, Aldoa, Pdha1, Pkm, Pfkm, Gpi1, Pck2, Eno3, Suclg, and Pgk1. (D)
Ikaros reduces ECAR, a measure of glycolysis (left) and the OCR (right) in B3 cells after 24 h (mean ± SEM of 3 biological replicates,
��P< 0.005, two-tailed t test). The numerical data underlying this figure are included in S1 Data. (E) Ikaros and the Ikaros family member
Aiolos reduce ECAR and OCR in primary B cell progenitors (mean ± SEM of 6 to 7 biological replicates, �P< 0.05, ��P< 0.005,
���P< 0.0001, one-tailed t test). The numerical data underlying this figure are included in S1 Data. (F) Impact of BLNK-mediated
induction of Ikzf3 on the expression of metabolic genes. The numerical data underlying this figure are included in S1 Data. (G) The
regulation of immune and housekeeping genes is coordinated at the level of cell populations and in single cells. BLNK, B cell linker; ChIP-
seq, chromatin immunoprecipitation sequencing; ECAR, extracellular acidification; Fr.C, proliferating B progenitor; Fr.D, differentiating
B cell progenitor; OCR, oxygen consumption rate; TCA cycle, tricarboxylic acid cycle.
https://doi.org/10.1371/journal.pbio.2006506.g002
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Fig 3. Systematic identification of candidate regulators of B cell progenitor differentiation. (A) Heat map of 23
candidate transcriptional regulators of B cell progenitor differentiation identified by 3 RNA-seq replicates at the indicated
time after Ikaros induction in B3 cells; expression trends are indicated. The source of the numerical data underlying this
figure is listed in S1 Data. (B) TWM analysis of Th17 differentiation. See text and S3 Fig for details and “Methods” for a
comprehensive mathematical description. (C) TWM analysis of the Fr.C to Fr.D transition based on target genes defined by
Feedforward regulation of Myc
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transcription factor and its target genes was determined for each time interval and summed
over the time series to yield a score for coherence. Finally, the score for transcription factor
expression and target enrichment over time was multiplied with the score for coherence to
yield a TWM score for each transcription factor. Details of this approach as well as a compre-
hensive mathematical description are provided in S3 Fig and in the “Methods” section.
We validated the TWM approach using the paradigm of T helper 17 (Th17) T-cell differen-
tiation, in which the key transcriptional drivers are known [32,33] and high-quality transcrip-
tion factor ChIP-seq data are available (S2 Table). TWM correctly identified RORC (TWM
score = 0.17), the signature transcription factor of Th17 cells, and IRF4 (TWM score = 0.14),
ChIP-seq identified RUNX1, FOXO1, and Myc as high-scoring regulators. (D) Progressive up-regulation of Foxo1 mRNA
and down-regulation of Myc mRNA with time after Ikaros induction. Shown is the mean of 3 independent RNA-seq
replicates. (E) Up-regulation of Foxo1 mRNA during in vivo B cell progenitor differentiation ([5]; www.immgen.org).
Down-regulation of Myc mRNA during in vivo B cell progenitor differentiation ([5]; www.immgen.org). (F) Ikaros ChIP-
seq [7] shows Ikaros binding to the promoter regions of Foxo1 and Myc. The established Ikaros target gene Igll1 is shown for
reference. ChIP-seq, chromatin immunoprecipitation sequencing; FOXO1, Forkhead Box O1; Fr.C, proliferating B cell
progenitor; Fr.D, differentiating B cell progenitor; Myc, MYC proto-oncogene; RNA-seq, RNA sequencing; RUNX1,
RUNT-related transcription factor; Th17, T helper 17; TWM, transition weight matrix.
https://doi.org/10.1371/journal.pbio.2006506.g003
Table 1. Differentially expressed transcription factors during B cell progenitor differentiation.
Factor ChIP-seq target no. DNase-seq target no. Inclusion criteria Direction In vivo log2 FC In vivo adj. P Ikaros target� DNase-seq TWM score
Arid5a N/A 1516 In vivo UP 1.043 0.006 1 1.808
Foxo1 2186 1154 In vivo UP 1.533 0.005 1 1.668
Mxd4 N/A 3192 In vivo UP 1.618 0.005 1 1.578
Hbp1 N/A 2312 In vivo UP 1.426 0.003 1 1.530
Sp100 N/A 7065 In vivo UP 1.268 0.004 0 1.414
Mybl2 N/A 2178 In vivo DOWN −1.025 0.005 1 0.902
Bach2 N/A 3338 In vivo UP 0.945 0.003 1 0.794
Jund N/A 2271 In vivo UP 2.177 0.003 1 0.426
Spi1 8572 4865 In vitro UP-DOWN 0.656 0.184 1 0.282
Myc 9269 3594 In vivo DOWN −3.426 0.001 1 0.240
Irf4 6237 2705 In vitro DOWN-UP 0.631 0.108 1 0.135
Nr1d1 N/A 3329 In vitro DOWN-UP −0.108 0.743 1 0.112
Runx1 215 4686 In vitro DOWN-UP 0.041 0.882 1 0.050
Rel N/A 1327 In vivo UP 0.868 0.003 1 0.026
Sp7 N/A 4128 In vitro DOWN-UP 0.130 0.533 0 0.016
Etv6 N/A 4253 In vitro DOWN-UP −0.038 0.887 1 0.009
Gfi1b N/A 1284 In vitro DOWN-UP −0.561 0.064 1 0.008
Klf2 N/A 5218 In vivo UP 1.825 0.009 1 0.007
Arid5b N/A 1126 In vivo UP 0.771 0.009 1 0.004
Hnf1b N/A 461 In vitro DOWN-UP 0.022 0.939 1 0.000
Tbx6 N/A 8 In vivo UP 1.279 0.003 1 0.000
Zfp629 N/A 264 In vitro DOWN-UP 0.350 0.157 1 0.000
Hoxb3 N/A 10 In vitro DOWN-UP 0.126 0.695 0 0.000
“In vivo” denotes differentially expressed between Fr.C and Fr.D B cell progenitors in vivo [5]. “In vitro” denotes differentially expressed during the time course of B3
cell differentiation. “Direction” denotes up- or down-regulation of the transcription factor.
�With the exception of Hoxb3, Sp7, and Sp100, the promoters of all 23 transcription factors are directly bound by Ikaros ChIP-seq peaks [7].
Abbreviations: adj., adjusted; ChIP-seq, chromatin immunoprecipitation sequencing; DNase-seq, DNase I hypersensitive sites sequencing; FC, fold change; Fr.C,
proliferating B cell progenitor; Fr.D, differentiating B cell progenitor; N/A, not applicable; TWM, transition weight matrix.
https://doi.org/10.1371/journal.pbio.2006506.t001
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which is required for Rorc expression, as transcription factors with the highest TWM score
(Fig 3B). c-Maf (Maf; TWM score = 0.14), a transcription factor with an established role in
Rorc induction and Th17 differentiation [34], and Hif1-alpha (Hif1a; TWM score = 0.12),
which controls the balance between Th17 and regulatory T (Treg) cell differentiation [35,36],
also scored highly. Therefore, TWM successfully identified key regulators of Th17 cell
differentiation.
To apply TWM to B cell progenitor differentiation, we retrieved published ChIP-seq data
sets for transcription factors in B cell progenitors. ChIP-seq data for the transcription factors
Runx1, Foxo1, Myc, Irf4, Spi1, and Jund, but ChIP-seq data for Jund did not contain statisti-
cally significant peaks by CLCbio Peak Finder [37]. This left Runx1, Foxo1, Myc, Irf4, and Spi1
as potential regulators for which potential target genes could be identified based on promoter-
proximal ChIPseq peaks (Table 1; proximal genes were identified by RGMatch [38]). We
included EBF1 and Pax5 as key factors of known importance for B cell differentiation and
CTCF as a negative control. Runx1 (TWM score = 1.75), Myc (TWM score = 1.20), and Foxo1
(TWM score = 1.14) were identified as highly ranked transcription factors (Fig 3C).
Runx1 showed transient down-regulation followed by up-regulation. RUNX1 ChIP-seq
target genes showed enrichment for differential expression (P< 0.0005) and good coherence
(Fig 3C). Foxo1 was progressively up-regulated and showed good enrichment for differential
expression of its ChIP-seq target genes (P< 0.001). Promoters bound by FOXO1 were mainly
up-regulated (P< 10 × 10−36). Myc was progressively down-regulated and also showed strong
enrichment for differential expression of its ChIP-seq target genes (P< 0.001). Promoters
bound by Myc were mainly down-regulated (P< 10 × 10−9). The relevance of FOXO1 and
Myc for primary B cell progenitor differentiation is supported by the up-regulation of Foxo1
mRNA and the down-regulation of Myc mRNA during in vivo B cell progenitor differentiation
(Fig 3E) and direct binding of Ikaros to the Foxo1 and Myc promoters in B cell progenitors
(Fig 3F).
For cell-state transitions for which sufficient ChIP-seq data are not available, TWM can be
implemented based on promoter accessibility and the presence of transcription factor motifs
in target gene promoters. We used DNase I hypersensitive sites sequencing (DNase-seq) to
assess promoter accessibility at each time interval and the presence of transcription factor
motifs for all 23 differentially expressed transcription factors (Table 1, Fig 3A). TWM identi-
fied Spib (TWM score = 2.62), Arid5a (TWM score = 1.81), Foxo1 (TWM score = 1.67), and
the Myc antagonist Mxd4 (TWM score = 1.58) as top-scoring transcription factors (Table 1).
For validation of the TWM results, we focused on Foxo1 and Myc for two reasons. First,
Foxo1 and the Myc pathway scored highly in both ChIP-seq and DNase-seq–based TWM
approaches. Second, Foxo1 and Myc show monotonic changes in expression (up- and down-
regulation, respectively) during the B3 cell differentiation time course, which facilitates the
analysis of their impact on B cell progenitor differentiation.
Transcriptional up-regulation of Foxo1 is linked to FOXO1 target gene
expression during B cell progenitor differentiation
FOXO1 is essential for B cell development, and its role in the progression from B cell progeni-
tor proliferation to B cell progenitor differentiation (i.e., the FR.C to Fr.D transition) has been
characterized in exquisite detail [8,9,11,39]. According to current models, Fr.C cells proliferate
in response to interleukin-7 (IL-7) receptor signaling, which inactivates FOXO1 via the phos-
phatidylinositol 3 kinase/Akt kinase/mechanistic target of rapamycin complex 1 (PI3K/Akt/
mTOR) axis (Fig 4Ai). Changes in signaling through the IL-7 receptor and/or pre–B cell recep-
tor lead to the post-translational activation and stabilization of FOXO1 protein (Fig 4Aii).
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Fig 4. Transcriptional regulation of FOXO1 target genes. (A) Scheme of post-translational (i and ii) and
transcriptional (iii) regulation of Foxo1 during B cell progenitor differentiation. (B) Western blotting for FOXO1
protein expression during the Fr.C to Fr.D transition. (C) Analysis of scRNA-seq time series data for a correlation
between Foxo1 mRNA level and the expression of FOXO1 target genes. FOXO1 target genes were defined by ChIP-seq
peaks in promoters as described above (black ORs and P values). Alternatively, FOXO1 target genes were defined
Feedforward regulation of Myc
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FOXO1 then induces the expression of target genes that are critical for B cell progenitor differ-
entiation and include B cell receptor signaling components, the recombinase activating genes
Rag1 and Rag2, and the immunoglobulin light chain loci Igk and Igl (Fig 4Aiii) [8,9,11]. We
confirmed that FOXO1 protein expression progressive increased during Ikaros-induced B3
cell differentiation (Fig 4B).
Our finding that Foxo1 mRNA increases over the time course of B3 cell differentiation and
also between the Fr.C to Fr.D B cell progenitor stages in vivo raise a hitherto unanswered ques-
tion about the role of FOXO1, namely, whether the transcriptional up-regulation we have
uncovered contributes to the regulation of FOXO1 target genes in B cell progenitor differentia-
tion. This is difficult to address by population RNA-seq data, because FOXO1 target genes
were differentially expressed during the Fr.C to Fr.D transition, concomitant with the increase
in Foxo1 mRNA (P< 10−13, for FOXO1 ChIP-seq targets versus nontargets, chi-squared test).
To address this conundrum, we interrogated scRNA-seq data. We asked whether Foxo1
mRNA was positively correlated with the expression of FOXO1 target gene transcripts at the
single-cell level and to what extent Foxo1 mRNA was a predictor of FOXO1 target gene expres-
sion independently of time. FOXO1 target genes were defined either by ChIP-seq peaks in pro-
moters as described above or, alternatively, as FOXO1-dependent genes that were deregulated
after genetic deletion of Foxo1 in early lymphoid/B cell progenitor cells [40]. We found signifi-
cant correlations between Foxo1 mRNA and FOXO1 target gene transcripts when comparing
cells with low versus intermediate versus high expression of Foxo1 transcripts (Fig 4C; see Fig
4D for examples).
We next used linear models to compute the extent to which the level of each differentially
expressed target gene was explained by time after 4-OHT addition, by Foxo1 mRNA level, or a
combination of time and Foxo1 mRNA level. Adding Foxo1 mRNA levels to the models signif-
icantly increased the fraction of the variance in FOXO1 target gene expression that could be
explained by time after 4-OHT addition alone (Fig 4E). The scRNA-seq analysis indicates that
the level of Foxo1 mRNA expression correlates with the expression of FOXO1 target genes in
the same cells.
Repression of Myc is required for the regulation of a subset of Ikaros target
genes in B cell progenitors
We next examined the regulatory relationship between Ikaros and Myc during B cell progeni-
tor differentiation. We transduced B3 cells with Myc-ERt2 or control vector (Fig 5A). In an
attempt to capture immediate Myc target genes in B3 cells, we isolated chromatin-associated
RNA [41] for high-throughput sequencing 30, 60, and 180 min after induction with 4-OHT.
Analysis over the time series (as described for Fig 1) identified 2,809 differentially expressed
based on the deregulation of genes after genetic deletion of Foxo1 in early lymphoid/B cell progenitor cells ([40] blue
ORs and P values). B3 cells with low, medium, and high Foxo1 mRNA level were analyzed separately (left), cells with
low and medium Foxo1 mRNA level were pooled (middle), or cells with medium and high Foxo1 mRNA level were
pooled (right). Genes were defined as significantly associated with Foxo1 if P< 0.01 (Fisher test). We conducted an
enrichment analysis comparing targets and nontargets. P values and ORs are shown. (D) Examples for the relationship
between Foxo1 mRNA and mRNA expression of selected FOXO1 targets in scRNA-seq time series data. The source of
the numerical data underlying this figure is listed in S1 Data. (E) The bars indicate the amount of variance (r2 values
calculated based on the difference between linear models) of FOXO1 target gene expression [40] after Ikaros induction
by 4-OHT treatment is accounted for by time, Foxo1 mRNA expression, and the combination of time and Foxo1
mRNA expression in scRNA-seq. The source of the numerical data underlying this figure is listed in S1 Data. ChIP-
seq, chromatin immunoprecipitation sequencing; FOXO1, Forkhead Box O1; Fr.C, proliferating B cell progenitor; Fr.
D, differentiating B cell progenitor; OR, odds ratio; scRNA-seq, single cell RNA sequencing; 4-OHT, 4-hydroxy-
tamoxifen.
https://doi.org/10.1371/journal.pbio.2006506.g004
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genes after Myc induction (adj. P< 0.05; 1,485 up, 1,241 down). As a reference, we transduced
B3 cells with Ikaros-ERt2 for chromatin-associated RNA-seq as described for Myc-ERt2. Anal-
ysis over the time series identified 1,354 differentially expressed genes after Ikaros induction
(adj. P< 0.05; 662 up, 692 down) (S4 Table and Fig 5B). Gene ontology (GO) analysis of
Ikaros-regulated genes showed enrichment of a spectrum of functional terms dominated by
adhesion, differentiation, signaling, kinase activity, phosphorylation, and metabolism (Fig 5B).
GO term analysis of Myc-regulated genes showed enrichment mainly of metabolism-related
terms within the time frame of these experiments (Fig 5B); 387 of the 1,354 Ikaros-regulated
genes identified by sequencing of chromatin-associated RNA were also differentially expressed
in response to Myc induction, and thus were responsive to regulatory inputs from Myc as
well as Ikaros. GO term analysis of these genes showed predominant enrichment of metabolic
genes (Fig 5B), similar to Myc-regulated genes. The remaining 967 Ikaros-regulated genes
were not differentially expressed in response to Myc induction. GO term analysis of these
genes showed enrichment mainly of adhesion, differentiation, the immune system, signaling,
kinase activity and phosphorylation (Fig 5B). Therefore, responsiveness to Myc separated
Ikaros target genes broadly into those related to metabolism (Myc-responsive) and differentia-
tion (Myc-unresponsive).
Fig 5. Inducible expression of Myc defines Myc-responsive and Myc-unresponesive Ikaros target genes. (A) Expression of Ikaros-ERt2 and Myc-ERt2 in B3 cells as
detected by western blotting. (B) Chromatin RNA-seq showed that the expression of 2,809 genes was regulated by Myc (adj. P< 0.05) and the expression of 1,978 genes
was regulated by Ikaros (adj. P< 0.05) in B3 cells. Of these, 587 genes were responsive to Myc and also to Ikaros (top). GO analysis of the biological function of Myc-
and Ikaros-regulated genes, and of Ikaros-regulated genes that are also regulated by Myc (Myc-responsive) or not regulated by Myc (not Myc responsive, bottom). The
top GO terms are shown; numbers and P values are indicated. The source of the numerical data underlying this figure is listed in S1 Data. ERt2, mutant estrogen
receptor; GO, gene ontology; HA, haemagglutinin; Myc, MYC proto-oncogene; RNA-seq, RNA sequencing.
https://doi.org/10.1371/journal.pbio.2006506.g005
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Ikaros and Aiolos directly bind to the Myc promoter and repress Myc at the transcriptional
level [7,18,42]. Whether repression of Myc is essential for coordinating the regulatory roles of
Ikaros and Myc in B cell progenitors is currently unknown, although it has been shown that
Myc can override the down-regulation of Ccnd3 (cyclin D3) and the up-regulation of the cell-
cycle inhibitor Cdkn1b (p27) by Ikaros and Aiolos [42]. These examples indicate that the regu-
lation of at least some Ikaros target genes requires the repression of Myc. This raises the ques-
tion of whether the regulation of target genes by Ikaros generally requires the down-regulation
of Myc or whether there are classes of Ikaros target genes that do and do not require Myc
repression. As an experimental system that removes Myc from the direct control of Ikaros, we
simultaneously transduced B3 cells with both Ikaros-ERt2 and Myc-ERt2 and sequenced chro-
matin-associated RNA as described above. Of the 1,354 Ikaros target genes identified by induc-
tion of Ikaros-ERt2 alone, 512 differentially expressed also in the presence of Myc (240 were
up-regulated, and 272 were down-regulated). We refer to these Ikaros target genes as “Myc-
resistant” (Fig 6A). The remaining 842 Ikaros target genes were only differentially expressed
(adj. P< 0.05) in response to Ikaros alone (422 up, 420 down) but were not differentially
expressed when Myc was expressed alongside Ikaros (Fig 6A and 6B). We refer to these
Ikaros target genes as “Myc-sensitive” (Fig 6A). This analysis defined distinct sets of Ikaros tar-
get genes that do or do not require the down-regulation of Myc: coexpression of Myc neutral-
ized the impact of Ikaros on Myc-sensitive target genes but not on Myc-resistant target genes
(Fig 6B).
GO analysis demonstrated that Myc-resistant Ikaros target genes were enriched for func-
tional terms related to signaling, adhesion, differentiation and development, and the immune
system (Fig 6A). By contrast, Myc expression did interfere with Ikaros regulation of target
genes related to metabolism, proliferation, and mRNA translation (Fig 6A). To ask whether
these differences separated B cell–specific from housekeeping genes, we classified Ikaros-regu-
lated genes during B cell progenitor differentiation as B cell specific or ubiquitously expressed.
As a measure for how broadly genes are expressed, we used tau-values compiled from mouse
Encyclopedia of DNA Elements (ENCODE) RNA-seq data across 22 tissues [43]. We assem-
bled a panel of broadly expressed genes with tau-values < 0.25 that were expressed > 0.5 frag-
ments per kilobase of exon model per million reads mapped (FPKM) in B3 cells as well as in
spleen (an organ rich in B cells), and a panel of tissue-specific genes with tau-values > 0.70
(also expressed > 0.5 FPKM in B3 cells and spleen).
We found that the distribution of tissue-specific and housekeeping genes was skewed
between Myc-sensitive and Myc-resistant Ikaros target genes. Housekeeping genes were
enriched among Myc-sensitive Ikaros targets (P = 0.019, odds ratio = 1.64), and B3 tissue-
specific genes were depleted among Myc-sensitive genes (P = 2.122 × 10−5, odds ratio = 0.42).
Conversely, Myc-resistant Ikaros target genes were enriched for B3-specific genes over house-
keeping genes (P value = 1.59× 10−7, odds ratio = 3.57). B3 tissue-specific genes were enriched,
and housekeeping genes were depleted among Myc-resistant Ikaros targets (Fig 6C). Valida-
tion experiments showed that Myc was able to override Ikaros in the regulation of most glycol-
ysis and glutaminolysis genes (S4A Fig) and substantially reduced the impact of Ikaros on
ECAR and OCR in metabolic flux assays (S4B Fig). Consistent with data in primary pre–B
cells [42], Myc also prevented Ikaros-imposed cell-cycle exit of B3 cells (S4C Fig). The regula-
tory relationship between Ikaros and Myc is illustrated by the target genes Igll1 (dominated by
Ikaros), Ccnd2 (dominated by Myc), and Slc2a1 (coregulated by Ikaros and Myc; S4D Fig).
Analysis of Ikaros ChIP-seq data showed that promoters that were up- or down-regulated
by Ikaros irrespective of Myc showed strong enrichment for Ikaros binding (P< 2.2 × 10−16,
odds ratio = 6.30 and P< 2.2 × 10−16, odds ratio = 4.05, respectively; Fig 6D). Myc-sensitive
Ikaros-regulated genes were also significantly enriched for Ikaros binding (P< 2.2 × 10−16,
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Fig 6. The regulatory relationship between Ikaros and Myc. (A) Of 1,978 genes that were regulated by Ikaros by chromatin RNA-seq (see Fig 5), 582 were also
significantly (adj. P< 0.05) regulated by Ikaros in the presence of inducible Myc (Myc-resistant Ikaros target genes). The remaining 1,396 Ikaros-regulated genes were
Myc sensitive, i.e., not significantly regulated by Ikaros in the presence of Myc (adj. P> 0.05). GO analysis of the biological function of differentially expressed genes in
response to Ikaros alone or Ikaros + Myc. The top GO terms are shown; numbers and P values are indicated. The source of the numerical data underlying this figure is
listed in S1 Data. (B) Heat map of log2 FCs of Myc-resistant and Myc-sensitive Ikaros target genes in B3 cells. The source of the numerical data underlying this figure is
listed in S1 Data. (C) Enrichment of B cell–specific gene sets and depletion of housekeeping genes among Myc-resistant Ikaros targets. Tissue-specific and housekeeping
genes were identified based on tau-values compiled from mouse ENCODE RNA-seq data across 22 tissues [43]. (D) Analysis of ChIP-seq data for HA-Ikaros binding at
Myc-sensitive and Myc-resistant Ikaros target gene promoters. P values were determined by Fisher exact test. Odds ratios> 1 indicate enrichment for Ikaros binding. (E)
Coordinated regulation of lineage-specific differentiation genes and housekeeping genes through feedforward regulation of Myc (left). Continued Myc expression
separates the regulation of differentiation and housekeeping genes (right). ChIP-seq, chromatin immunoprecipitation sequencing; ENCODE, encyclopedia of DNA
elements; FC, fold change; GO, gene ontology; HA, haemagglutinin; Myc, MYC proto-oncogene; RNA-seq, RNA sequencing.
https://doi.org/10.1371/journal.pbio.2006506.g006
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odds ratio = 5.92 for down-regulated and P< 1.7 × 10−13, odds ratio = 2.08 for up-regulated
genes compared to all expressed genes; Fig 6D), suggesting that many promoters may receive
regulatory inputs from both Ikaros and Myc.
The picture emerging from this analysis is that Ikaros regulates both ubiquitous and tissue-
specific genes. Regulation of most ubiquitous genes by Ikaros is broadly sensitive to Myc dos-
age, whereas regulation of many tissue-specific genes by Ikaros is resistant to Myc dosage.
These data are consistent with the existence of a regulatory circuit whereby Ikaros down-regu-
lates Myc, and target gene expression reflects the combined effect of Ikaros expression and
Myc down-regulation. The data suggest a model of progenitor cell differentiation in which the
regulation of lineage-specific differentiation genes is coordinated with that of housekeeping
genes. In B cell progenitor cell differentiation, such coordination is achieved by feedforward
regulation of Myc by Ikaros; Fig 6E, left). Continued Myc activity interferes with the regulation
of housekeeping functions and abolishes the coordinated regulation of housekeeping and line-
age-specific differentiation genes (Fig 6E, right). This model is consistent with the known role
of Myc as a major regulator of metabolism, the cell cycle, and RNA transcription and transla-
tion [44] and provides a framework for how Ikaros-mediated Myc repression contributes to
differential gene expression during B cell progenitor differentiation.
Discussion
To identify transcriptional pathways that drive B cell progenitor differentiation, we developed
the TWM algorithm, which identifies coherence between transcription factors downstream of
Ikaros induction and their target gene expression over time. This approach pinpointed the
transcriptional up-regulation of Foxo1 up-regulation and the repression of Myc as important
components of Ikaros-mediated B cell differentiation.
FOXO1 target genes are integral to Fr.D, including immunoglobulin light gene rearrange-
ment [8,9,11]. Previously, several studies have shown that FOXO1 protein is activated and sta-
bilized at the post-translational level during B cell progenitor differentiation [8,9,11]. Here, we
demonstrate that the progressive transcriptional up-regulation of Foxo1 correlates with the
expression of FOXO1 target genes at the single cell level. Perturbation experiments will be
required to establish the extent to which transcriptional regulation of Foxo1 is a functional
contributor to FOXO1 target gene expression during B cell progenitor differentiation.
The coordination between proliferation, metabolic state, and differentiation is essential for
normal development and homeostasis and has been attributed to antagonism between tran-
scription factors that induce tissue-specific gene expression and cyclin-dependent kinases that
promote cell-cycle entry [1–3]. By means of perturbation experiments designed to disrupt
feedforward repression of Myc by Ikaros, we demonstrate that the regulation of lineage-spe-
cific differentiation genes can be dissociated from that of ubiquitously expressed genes, simply
by uncoupling pathways by which Ikaros acts as an inducer of B cell progenitor differentiation
from the repression of Myc.
Destabilization of one state and implementation of another has been studied extensively in
cellular reprogramming [45–47], and our analysis introduces a similar idea to progenitor cell
differentiation. Repression of Myc extinguishes key features of the undifferentiated state, and
up-regulation of Ikaros family transcription factors—Foxo1, and presumably others—pro-
motes a shift to the differentiated state. Consistent with this model, metabolic Myc target
genes [48] were mostly repressed (S5B Fig), whereas FOXO1 target genes related to signaling,
adhesion, and the immune system were mainly up-regulated (S5B Fig). Reminiscent of the sce-
nario described here, FOXO and Myc control cell proliferation and metabolism in endothelial
cells [49]. In B cell progenitors, both Myc and Foxo1 are direct targets of Ikaros, which links
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the extinction of the Fr.C-like state and establishment of the Fr.D-like state. Integration
between cell type–specific and ubiquitous gene expression programs by interconnected regula-
tors may account for other cell-state transitions.
Methods
Ethics statement
Mouse work was performed according to the Animals (Scientific Procedures) Act under the
authority of project licence PPL70/7556 issued by the Home Office, United Kingdom. All
work with mouse cells was in vitro, and the ARRIVE checklist is not applicable.
Cell culture, retroviral transduction, RNA, and protein methods were as described by Fer-
reiro´s and colleagues [7]. Isolation of chromatin-associated RNA was done as described by Ma
and colleagues [42].
RNA-seq
To control for sources of variability, we implemented a scheme that tracks biological batches
(3), conditions (Ikaros or control vector), time points (6), library preparations (6 × 6), bar
codes, sequencing runs, and flow cell lanes. Each RNA-seq library was split into two (total
of 72) to account for variability associated with sequencing. For sequencing, the 72 libraries
were distributed across 4 flow cells with 3 libraries per flow cell. Each lane contained different
libraries, batches, time points, and conditions. We aimed for 50 million reads per library × 4
sequencing runs, equaling 100 million reads per sample. Strand-specific libraries were
sequenced on an Illumina HiSeq 2500, at 75 nucleotides paired-end. Analysis followed pub-
lished guidelines [50] using Tophat2 “very-sensitive” mode only allowing a unique best map-
ping to map sequences to the mm10 reference genome. Trimming was applied to remove
Illumina primers and low-quality nucleotides. ht-seq intersection-option was used to assign
fragments to genes. We used cqn to correct for GC content and gene-length bias and a non-
parametric version of ComBat to correct for RNA-seq library-preparation effects.
We identified differential expression by combining limma [19] to identify sharp changes
and maSigPro [20] to identify changes over time. In limma, we computed significant differ-
ences between Ikaros (4-OHT and Ikaros effects) and control (4-OHT effects)—between con-
secutive time points and between every time point and 0 h. To compute a final limma-derived
P value for each gene, we combined all contrasts using eBayes function of limma and com-
puted the F-statistic, the associated P value, and the adj. P value (using Benjamini-Hochberg
multiple testing correction). In maSigPro, we considered 2 conditions (Ikaros and control)
and identified genes whose trends separated over time. We considered a gene to be differen-
tially expressed if any of the following conditions applied: (a) limma FDR< 0.001, (b) maSig-
Pro R2 > 90%, or (c) limma FDR < 0.01 and maSigPro R2 > 60%.
Gene expression microarray analysis
We used limma to analyze gene expression array data from www.immgen.org.
Gene set analysis
We used Generally Applicable Gene-set Enrichment [51] to perform gene set analysis over
ranked lists of genes [52] and Fisher test to perform gene set analysis over clusters of genes.
We used default parameters and defined as significant those gene sets with associated Benja-
mini-Hochberg adj. P< 0.1. We used gene sets included in the GSKB Bioconductor package
[53].
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TWM
S3 Fig describes the analysis step by step. A mathematical description is given in “Notation.”
Notation
1. Time T = (x1, x2, . . ., xA)
2. Differences between consecutive timesrT ¼ frx2   x1 ;rx3   x2 ; . . . ; rxA   xA  1g
3. Consecutive Contrasts CrT ¼ fðrx2   x1 ;rx3   x2Þ; ðrx3   x2 ;rx4   x3Þ; . . . ; ðrxA  1   xA  2 ;rxA   xA  1Þg
4. Transcription Factors TF = {tf1, tf2, . . ., tfF}
5. Genes G = {g1, g2, . . ., gTg}
6. Binding Information Graph BIG ¼ TF; G; btfj;gj ¼
1 if tfi binds gj
0 otherwise
( )
7. Differential expression DEI ¼ rT; G; deira ;gj ¼
1 if gj differentially expressed atra
0 otherwise
( )
8. log2 fold-change: logarithm 2 transformation of the fold change of a given gene
9. OR: odd ratio quantifying the enrichment of a transcription factor targets over differentially
expressed genes
Step 1: Log2 fold change
1. Computing log2 fold change per contrast:
8 tfi 2 TF; 8rj 2 r
T estimate logFCtfi ;rj
2. Computing aggregated log2 fold change for consecutive contrasts:
8tfi 2 TF; 8Crj ¼ ðra;rbÞ 2 Cr
Testimate logFCtfi;Crj ¼ logFCtfi ;ra þ logFCtfi ;rb
Step 2: Odds ratios
1. Computing odds ratios:
8 tf 2 TF; 8rj 2 r
T estimate ORtfi;rj
2. Computing aggregated log2 fold change for consecutive contrasts
8tfi 2 TF; 8Crj ¼ ðra;rbÞ 2 Cr
Testimate ORtfi ;Crj ¼ ORtfi ;ra þ ORtfi ;rb
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Step 3: Coherence
1. Computing direction for all genes and transcription factors for all contrasts:
8 g 2 G; 8rj 2 r
T estimate signg;rj ¼ signðlogFCg;rjÞ
8 tfi 2 TF; 8rj 2 r
T estimate signtfi ;rj ¼ signðlogFCtfi ;rjÞ
2. Computing coherence per transcription factor for each gene and for each consecutive con-
trast:
8 tfi 2 TF;
8 Crj ¼ ðra;rbÞ 2 Cr
T;
8 g 2 G j btfi ;g ¼ 1 ^ deira ;g ¼ 1 ^ deirb ;g ¼ 1;
compute cohg;tfi ;Crj ¼
1 if signg;ra � signg;rb � signtfi ;ra � signtfi;rb > 0
0 otherwise
3. Computing coherence per transcription factor per consecutive contrast:
8 tfi 2 TF; 8Crj ¼ ðra;rbÞ 2 Cr
T; 8 g 2 G j btfi ;g ¼ 1 compute
compute cohtfi;Crj ¼
P
8 g 2G j btfi ;g¼1
cohg;tfi ;Crj
# g 2 G j btfi ;g ¼ 1 ^ deira ;g ¼ 1 ^ deirb ;g ¼ 1
Step 4: Combine
1. Combine log2 fold change and odds ratio measurements:
8 tfi 2 TF; combtfi ¼
X
8 Crj 2 Cr
logFCtfi ;Crj�ORtfi ;Crj
2. Combine all coherence:
8 tfi 2 TF; cohtfi ¼
Y
8 Crj 2 Cr
cohtfi ;Crj
3. Combine all measurements:
8 tfi 2 TF; TWMtfi ¼ combtfi�cohtfi
B-ALL analysis
CEL files for 1404 B-ALL patients were obtained from their respective publications [23,54–57].
The raw data were normalized together with the Robust Median Average (RMA) algorithm,
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whereas systematic variations across studies were eliminated using ComBat. Differentially
expressed genes between Ikaros-mutated and Ikaros wild-type subjects were identified with
limma, using surrogate Variable Analysis [58] to account for possible latent confounders.
Pathway enrichment analysis was performed using (a) mean-rank gene set enrichment [59] on
gene sets from the Molecular Signature Database [52] and (b) GSEA [52] on Ikaros targets
identified by Chip-seq in mouse B3 cells. Enrichment analysis was repeated on the 10,111
genes expressed in B3 cells.
ChIP-seq data bioinformatics analysis
We analyzed ChIP-seq data for B cell–associated transcription factors (S3 Table). EBF1, PU.1,
IRF4 [15], PAX5 [60], CTCF [6], and RUNX1 [61] were from pro–B cells; FOXO1 was from
pre–B cells [8]; Myc was from CH12 cells [62]; and Ikaros was from B3 cells [7]. We used Bow-
tie2 [63] for mapping to the mm10 reference genome. When fastq files were available, we used
“end-to-end” and “very-sensitive” parameters, otherwise we used “local” parameter. In all
cases, we filtered duplicated reads and any reads with quality scores below 20. We applied
CLCbio Peak Finder tool [37] to identify peaks for each sample using default parameters; we
used control libraries when available (S1 Table). We considered peaks with adj. P< 0.01.
DNase-seq profiling
DNase-seq was performed on 20 to 25 million cells with 3 biological replicates for all time
points and conditions. Briefly, cells were harvested and washed with cold 1× PBS. Lysis condi-
tions were optimized to ensure>90% recovery of intact nuclei. Enrichment of DNaseI hyper-
sensitive fragments (0–500 bp) was performed using a low-melt gel size selection protocol.
Library preparation was performed and sequenced as 43-bp paired-end NextSeq 500 Illumina
reads. DNaseI libraries were sequenced at a minimum depth of 20 million reads per each bio-
logical replicate and a total of 200 million per time and condition. DNase-seq reads were
trimmed to 36 bp and paired-end mapped to the mm10 reference genome using Bowtie2 [63]
with the following options: -v 2 -k 1 -m 1—best–strata. We used Wellington to identify the
footprinting sites per time and condition [64]. We used MATCH algorithm from TRANSFAC
to predict binding sites (BSs) of transcription factor motifs in FP. To minimize the number of
false positive BS predictions we defined an FOS-related optimal threshold by using as a gold-
standard the ChIP-seq IKZF1 peaks. We identified the optimal level of FOS [64] at which
DNase-seq–derived Ikzf1 BS predictions obtained by MATCH were optimally (minimizing
false positives) predicting CHIP-seq IKZF1 peaks. Proximal genes for ChIP-seq–and DNase-
seq–derived peaks were identified with default parameters in RGmatch [38].
scRNA-seq profiling
We isolated cells using the Fluidigm C1 System. Single-cell C1 runs were completed using the
smallest IFC (5–10 μm). Cells were collected at a concentration of 400 cells/μl in a total of 50 μl.
To optimize cell capture rates on the C1, buoyancy estimates were optimized prior to each run.
Single-cell capture efficiency was between 75% and 90% across 8 runs. Each C1 capture site was
visually inspected for single-cell capture and cell viability. After visualization, the IFC was loaded
with Clontech SMARTer kit lysis, RT, and PCR amplification reagents. After harvesting, cDNA
was normalized across all libraries from 0.1 to 0.3 ng/μl, and libraries were constructed using
Illumina’s Nextera XT library prep kit per Fluidigm’s protocol. Constructed libraries were multi-
plexed and purified using AMPure beads. The final multiplexed single-cell library was analyzed
on an Agilent 2100 Bioanalyzer for fragment distribution and quantified using Kapa Biosystem’s
universal library quantification kit. The library was normalized to 2 nM and sequenced as 75-bp
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paired-end dual indexed reads using Illumina’s NextSeq 500 system at a depth of approximately
1.0 to 2.0 million reads per library. Each Ikaros time point was performed once, with the excep-
tion of 18- and 24-h time points, in which 2 C1 runs were required in order to achieve approxi-
mately 50 single-cells per time point. We mapped 560 scRNA-seq libraries with Tophat2 [65] to
the mouse Ensembl gene annotations and mm10 reference genome. We excluded single-cell
libraries with a mapping rate less than 50% and less than 450,000 mapped reads; we obtained a
total of 324 single cells for all subsequent analysis. Cufflinks [66] version 2.2.1 was used to quan-
tify expression from single-cell libraries using Cuffquant. Gene expression data for each single-
cell library were merged and normalized into a single data matrix using Cuffnorm. Monocle
[21] was used to compute pseudotime trajectories, in which cells are ordered by their actual
progress in the differentiation course rather than by their experimental time point.
Validation of Foxo1 expression and FOXO1 targets in single cells
We filtered for cells with expression greater than 0 and grouped cells based on quantiles 0.33
and 0.66 of Foxo1 expression levels (3 levels: low, middle, and high). Then we did the same for
each gene. Using both groupings, we computed a contingency table (Fig 6C, left panel) and a P
value for each gene and defined genes as significantly regulated and not significantly regulated.
We found that significantly regulated genes were enriched in FOXO1 targets (P = 0.05). We
repeated the analysis, first by combining low and middle into a single level (Fig 5C, middle
panel, P< 0.05) and second by combining middle and high into a single level (Fig 5C,
right panel, P< 0.07). Finally, we combined all significantly regulated definitions and consid-
ered a gene to be Foxo1 regulated if the contingency table analysis was significant for any of
the 3 analyses. In this case, significantly regulated genes were enriched in FOXO1 targets
(P< 0.001). To quantify and compare the role of time and Foxo1 mRNA levels in FOXO1
targets, we first filtered for cells with expression greater than 0 for each gene pair. Then we
computed 2 linear models: in the first one, mRNA gene expression was predicted using time;
in the second, mRNA gene expression was predicted using a 6-level grouping of Foxo1 mRNA
expression. Finally, for each gene we compared the r2 values derived from each model.
Measurement of ECAR and OCR was done using Seahorse XF24 or XF96 extracellular flux
analyzers as advised by the manufacturers (Seahorse Bioscience; North Billerica, MA). To
assess the impact of Ikaros and Aiolos on ECAR and OCR, primary B cells were transduced
with IRES-GFP, Ikzf1-IRES-GFP, or Ikzf3-IRES-GFP; sorted for GFP expression 72 h later;
and rested for 3 to 6 h in cultured in the presence of IL-7.
Categorization of GO terms in broad functional classes
“Immune system” includes the terms “immune,” “host defense,” “B cell,” “T cell,” “myeloid,”
“lymphocyte,” “leukocyte,” and “hematopoiesis.” “Signaling” includes the terms “signal,” “sig-
naling,” “response,” “stimulus,” “communication,” and “activation.” “Adhesion” includes the
terms “adhesion” and “integrin.” “Differentiation” includes the terms “differentiation” and
“development.” “Metabolism” includes the terms “metabolic,” “metabolism,” “biosynthetic,”
“biosynthesis,” and “catabolic.” “Translation” includes the terms “translation,” “ribosome,”
and “ribonuclear.” “Proliferation” includes the terms “proliferation,” “chromatid,” “spindle,”
“mitosis,” “mitotic,” “cell cycle,” “cell division,” “DNA synthesis,” and “DNA replication.”
Supporting information
S1 Data. Underlying data for figures.
(XLSX)
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S1 Fig. Ikaros target genes identified during B cell progenitor differentiation are deregu-
lated in IKZF1-mutant B-ALL. We assembled gene expression profiles of 1,404 B-ALL sam-
ples with and without IKZF1 mutations [23,54–57]. IKZF1 was mutated in 406 samples (29%).
B-ALL samples with and without IKZF1 mutations differed in 7,222 genes (0.1 FDR; S1A Fig)
[67,68] with significant enrichment for 317 of 1,415 gene sets in the molecular signature data-
base [69] (P< 5 × 10−4), including FOXO, Myc, and CXCR4 pathways, adherens junction, cell
cycle, integrin-, B cell receptor-, PI3K-, ERK-, MAPK-, and NF-kB signaling pathways, and the
PYK2 pathway, which links leukemia with cell adhesion [25] (S5 Table). Among B-ALLs with
BCR-ABL1 translocations, 71% had IKZF1 mutations; 1,228 genes were differentially expressed
in IKZF1 mutated samples (S1B Fig) with enrichment of FOXO, Myc, CXCR4, chemokine sig-
naling, cell cycle, transcription, adherens junction, focal adhesion kinase, integrin, and B cell
receptor signaling as well as the downstream transduction pathways PI3K, ERK, MAPK, NF-
kB, and NFAT (P< 5 × 10−4, S6 Table). Differentially expressed genes in IKZF1-mutated
B-ALL were enriched for Ikaros target genes identified by ChIP-seq in mouse B3 cells (S1C
Fig, P = 0.0189 for all samples and P = 0.0017 for BCR-ABL1 samples). There was significant
overlap between differentially expressed genes in IKZF1-mutated B-ALL and early Ikaros tar-
gets regulated between 0 and 2 h after 4-OHT (Fig 1F, odds ratio = 2.53, adj. P = 0.02 for the
200 most differentially expressed genes). Analysis of the BCR-ABL subset of B-ALL samples
identified JAK-STAT (S1D–S1F Fig), G-protein coupled receptor and cytokine signaling (S6
Table). Gene-based prognostic models define subgroups of B-ALL with poor clinical outcome
[17,28,70], and a set of 139 asparaginase and vincristine resistance genes [70] was enriched for
differential expression during the Fr.C to Fr.D transition (P< 0.05). A 256-probe set “Ph+like”
signature indicative of poor prognosis [17] was significantly enriched among genes differen-
tially expressed at 2, 6, and 12 h (all P< 0.05) after nuclear translocation of Ikaros. Combining
2 distinct Ph+like signatures [17,28] resulted in enrichment at all time points (P< 0.05). As a
control for the overlap in gene expression between Ikaros-induced B3 cells and IKZF1 muta-
tions in B-ALL, we used recurrent non-IKZF1 genetic lesions in AML, or B-ALL with 4-OHT-
treated B3 cells transduced with ERt2 control vector instead of Ikaros-ERt2. Therefore, analysis
of B cell progenitor cell state transitions can reveal gene expression signatures with relevance
to human disease. (A, B) Differential expression in 1,404 B-ALL samples (A) and of the
BCR-ABL1 subset (B). Log2 fold change between wild-type and IKZF1-mutated samples log10
adj. P values are indicated. Dashed line: log2 fold change > 0.5; blue: FDR> 0.1. The sources
of the numerical data underlying this figure are listed in S1 Data. (C) GSEA of Ikaros-bound
genes identified by ChIP-seq in mouse B3 cells in genes differentially expressed in IKZF1-mu-
tated versus nonmutated human B-ALL. The x-axis is the list of genes ordered by magnitude
of differential expression, whereas the y-axis represents the enrichment score for the Ikaros tar-
get gene set computed by the GSEA method. The red dashed line indicates the maximum
reached by the enrichment score. (D) JAK-STAT signaling pathway in B-ALL. (E,F) JAK-
STAT signaling pathway changes between 0 h to 2 h (B) and 0 h to 6 h (C) during the Fr.C to
Fr.D transition in vitro. No such overlap was seen when contrasting Ikaros-induced B3 cells
with recurrent (non-IKZF1) genetic lesions in AML, or B-ALL with 4-OHT-treated B3 cells
transduced with ERt2 control vector instead of Ikaros-ERt2. adj., adjusted; AML, acute mye-
loid leukemia; B-ALL, B cell progenitor acute lymphoblastic leukemia; BCR-ABL1, B-ALL
with translocations between the IGH locus and the ABL1 proto-oncogene; ChIP-seq, chroma-
tin immunoprecipitation sequencing; CXCR4, C-X-C chemokine receptor type 4; ERK, extra-
cellular signal–regulated kinase; ERt2, mutant estrogen receptor; FDR, false discovery rate;
FOXO, Forkhead Box O; Fr.C, proliferating B cell progenitor; Fr.D, differentiating B cell pro-
genitor; GSEA, Gene Set Enrichment Analysis; JAK-STAT, Janus kinase/signal transducers
and activators of transcription; MAPK, mitogen activated kinase; Myc, MYC proto-oncogene;
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NFAT, nuclear factor of activated T cells; NF-kB, nuclear factor kappa-light-chain-enhancer
of activated B cells; PI3K, phosphatidylinositol 3 kinase; PYK2, proline-rich tyrosine kinase 2;
4-OHT, 4-hydroxy-tamoxifen.
(PNG)
S2 Fig. Reduced mTORC1 activity and expression of autophagy regulators during B cell
progenitor differentiation. (A) Ikaros-induced reduction in mTORC1 activity as indicated by
the reduced phosphorylation of ribosomal S6 protein on Ser235/236 and Ser240/244. (B) Tran-
scriptional up-regulation of autophagy regulators during the Fr.C to Fr.D transition in vitro
and in vivo. The source of the numerical data underlying this figure is listed in S1 Data. Fr.C,
proliferating B cell progenitor; Fr.D, differentiating B cell progenitor; mTORC1, mechanistic
target of rapamycin complex 1.
(PNG)
S3 Fig. Step-by-step account of TWM. TWM ranks TFs by combining 3 sources of informa-
tion: (i) TF binding to gene promoters in B cell progenitors from publicly available ChIP-seq
data, (ii) differential expression within the Ikaros time series between consecutive time points
and over the entire time span (0–24 h), and (iii) coherence between the expression of TFs and
their targets over time. The approach has 4 steps: (1) For each TF, log2 fold change in expres-
sion is averaged for each consecutive pair of contrasts (red). (2) Enrichment of TF binding
over differentially expressed genes is averaged for each consecutive pair of contrasts (yellow).
(3) For each TF, coherence is determined between expression of the TF and its target genes
over time (blue). (4) The log2 fold change and odds ratio for each pair of contrasts are multi-
plied to generate a combination matrix (gray, center), and the sum of these values is multi-
plied with the global coherence score to determine the final TWM score (gray, right). ChIP-
seq, chromatin immunoprecipitation sequencing; TF, transcription factor; TWM, transition
weight matrix.
(PNG)
S4 Fig. Myc partially overrides the impact of Ikaros on metabolic gene expression and
function. (A) Interactions between Ikaros and Myc in metabolic gene regulation. P values
refer to Ikaros versus control vector (left) and Ikaros versus Ikaros + Myc (right). The numeri-
cal data underlying this figure are included in S1 Data. (B) Interactions between Ikaros and
Myc in the regulation of metabolic functions, ECAD and OCR. P values refer to Ikaros versus
control vector (left) and Ikaros versus Ikaros + Myc (right). The numerical data underlying
this figure are included in S1 Data. (C) Myc overrides Ikaros-imposed cell-cycle arrest in B3
cells. (D) Schematic representation of the regulatory relationships between Ikaros and Myc
at selected target genes. The numerical data underlying this figure are included in S1 Data.
ECAD, extracellular acidification rate; Myc, MYC proto-oncogene; OCR, oxygen consump-
tion rate.
(PNG)
S5 Fig. An updated network of B cell progenitor differentiation. Based on [8], the model
incorporates previous [12,42] and current data. Phase 1 is dominated by IL-7 signaling (panel
A; blue indicates posttranslational regulation), phase 2 by FOXO1, pre-B cell receptor signal-
ing, and Ikaros (B). Of 21 validated Myc target genes in core metabolism [30], 19 were differ-
entially expressed during the Fr.C to Fr.D transition. Of these, 18 were down-regulated and 1
was up-regulated. Of 2,186 putative FOXO1 target genes defined by FOXO1 promoter bind-
ing, 685 were up- and 308 were down-regulated, including genes related to signaling (81 up-
and 24 down-regulated), adhesion (31 up- and 6 down-regulated), and the immune system (23
up- and 10 down-regulated). The source of the numerical data underlying this figure is listed
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in S1 Data. BCR; FOXO1; Fr.C, proliferating B cell progenitor; Fr.D, differentiating B cell pro-
genitor; IL-7, interleukin-7; Myc, MYC proto-oncogene.
(PNG)
S1 Table. Differential expression summary in B3 RNA-seq time series. Limma.P.value
(Limma.adj.P.Val) denotes the P values of the moderated F-statistic test using limma [19].
MaSigProPval and R2 denote the P value and the r-squared of the linear model computed
using the MaSigpro tool [20]. CONSENSUS_DE is 1 for those genes that were characterized as
differentially expressed (see Methods). logFC and Adjp denotes fold change and adjusted P
value, respectively, for each contrast. RNA-seq, RNA sequencing.
(XLSX)
S2 Table. ChIP-seq data sets for Th17 TWM analysis. ChIP-seq, chromatin immunoprecipi-
tation sequencing; Th17, T helper 17; TWM, transition weight matrix.
(XLSX)
S3 Table. ChIP-seq data sets selected for the B3 TWM analysis. Mapping, filtering, and peak
columns describe the methodology used in each case, dependent on the quality of reads and
availability of background samples. Cell column denotes the cell type analyzed. ChIP-seq;
TWM, transition weight matrix.
(XLSX)
S4 Table. Genes differentially regulated by Ikaros and Myc. Myc.
(XLSX)
S5 Table. B-ALL pathway enrichment, all samples. B-ALL, B cell progenitor acute lympho-
blastic leukemia.
(XLSX)
S6 Table. B-ALL pathway enrichment, BCR-ABL samples. B-ALL, B cell progenitor acute




We thank Dr. James Elliott for cell sorting and Drs. David Carling and Dominic Withers for
fruitful discussions. This study makes use of data generated by the St. Jude Children’s Research
Hospital—Washington University Pediatric Cancer Genome Project. VL thanks Drs. Monique
L. Den Boer, Judith M. Boer, William L. Carroll, Julia Meyer, and Ilaria Iacobucci for provid-
ing access to data and Argyro Karozou for help with analysis.
Author Contributions
Conceptualization: Amanda G. Fisher, Ioannis Tsamardinos, Ali Mortazavi, Boris Lenhard,
Ana Conesa, Jesper Tegner, Matthias Merkenschlager.
Data curation: Thomas Carroll, Vincenzo Lagani, Ricardo N. Ramirez, Georgios Papoutso-
glou, Gopuraja Dharmalingam, Ya Guo, Ana Conesa, David Gomez-Cabrero.
Formal analysis: Isabel Ferreiro´s-Vidal, Thomas Carroll, Vincenzo Lagani, Ricardo N.
Ramirez, Elizabeth Ing-Simmons, Georgios Papoutsoglou, Gopuraja Dharmalingam, Ya
Guo, Sonia Tarazona, Sunjay J. Fernandes, Gilad Silberberg, Boris Lenhard, Matthias Mer-
kenschlager, David Gomez-Cabrero.
Feedforward regulation of Myc
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006506 April 12, 2019 24 / 28
Funding acquisition: Amanda G. Fisher, Ana Conesa, Jesper Tegner, Matthias
Merkenschlager.
Investigation: Isabel Ferreiro´s-Vidal, Tianyi Zhang, Ricardo N. Ramirez, Alicia G. Go´mez-
Valade´s, Lee Cooper, Ziwei Liang, Ya Guo, Sunjay J. Fernandes, Peri Noori, David Gomez-
Cabrero.
Methodology: David Gomez-Cabrero.
Supervision: Isabel Ferreiro´s-Vidal, Ioannis Tsamardinos, Ali Mortazavi, Boris Lenhard, Ana
Conesa, Jesper Tegner, Matthias Merkenschlager.
Visualization: Isabel Ferreiro´s-Vidal, Elizabeth Ing-Simmons, Alicia G. Go´mez-Valade´s,
Georgios Papoutsoglou, Gopuraja Dharmalingam.
Writing – original draft: Matthias Merkenschlager.
Writing – review & editing: Tianyi Zhang, Amanda G. Fisher, Ana Conesa, Jesper Tegner,
Matthias Merkenschlager, David Gomez-Cabrero.
References
1. Ruijtenberg S, van den Heuvel S. Coordinating cell proliferation and differentiation: Antagonism
between cell cycle regulators and cell type-specific gene expression. Cell Cycle. Taylor & Francis;
2016; 15: 196–212. https://doi.org/10.1080/15384101.2015.1120925 PMID: 26825227
2. Soufi A, Dalton S. Cycling through developmental decisions: how cell cycle dynamics control pluripo-
tency, differentiation and reprogramming. Development. 2016; 143: 4301–4311. https://doi.org/10.
1242/dev.142075 PMID: 27899507
3. Agathocleous M, Harris WA. Metabolism in physiological cell proliferation and differentiation.
Trends Cell Biol. Elsevier Ltd; 2013; 23: 484–492. https://doi.org/10.1016/j.tcb.2013.05.004 PMID:
23756093
4. Hardy RR, Carmack CE, Shinton S a, Kemp JD, Hayakawa K. Resolution and Characterization of Pro-
B and Pre-Pro-B Cell Stages in Normal Mouse Bone Marrow. J Exp Med. 1991; 173: 1213–1225.
PMID: 1827140
5. Painter MW, Davis S, Hardy RR, Mathis D, Benoist C. Transcriptomes of the B and T lineages com-
pared by multiplatform microarray profiling. J Immunol. 2011; 186: 3047–57. https://doi.org/10.4049/
jimmunol.1002695 PMID: 21307297
6. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, et al. A global network of tran-
scription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol. Nature
Publishing Group; 2010; 11: 635–43. https://doi.org/10.1038/ni.1891 PMID: 20543837
7. Ferreiro´s Vidal I, Carroll T, Taylor B, Terry A, Liang Z, Bruno L, et al. Genome-wide identification of
Ikaros targets elucidates its contribution to mouse B cell lineage specification and pre-B cell differentia-
tion. Blood. 2013; 121: 1769–1782. https://doi.org/10.1182/blood-2012-08-450114 PMID: 23303821
8. Ochiai K, Maienschein-Cline M, Mandal M, Triggs JR, Bertolino E, Sciammas R, et al. A self-reinforcing
regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immu-
nol. 2012; 13: 300–307. https://doi.org/10.1038/ni.2210 PMID: 22267219
9. Clark MR, Mandal M, Ochiai K, Singh H. Orchestrating B cell lymphopoiesis through interplay of IL-7
receptor and pre-B cell receptor signalling. Nat Rev Immunol. Nature Publishing Group; 2014; 14: 69–
80. https://doi.org/10.1038/nri3570 PMID: 24378843
10. Desiderio S, Lin W, Liz Z. The cell cycle and V(D)J recombination. Curr Top Microbiol Immunol. 1996;
217: 45–59. PMID: 8787617
11. Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor
signalling. Nat Rev Immunol. 2009; 9: 195–205. https://doi.org/10.1038/nri2491 PMID: 19240758
12. Thompson EC, Cobb BS, Sabbattini P, Meixlsperger S, Parelho V, Liberg D, et al. Ikaros DNA-Binding
Proteins as Integral Components of B Cell Developmental-Stage-Specific Regulatory Circuits. Immu-
nity. 2007; 26: 335–344. https://doi.org/10.1016/j.immuni.2007.02.010 PMID: 17363301
13. Heizmann B, Kastner P, Chan S. Ikaros is absolutely required for pre-B cell differentiation by attenuat-
ing IL-7 signals. J Exp Med. 2013; 210: 2823–32. https://doi.org/10.1084/jem.20131735 PMID:
24297995
Feedforward regulation of Myc
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006506 April 12, 2019 25 / 28
14. Joshi I, Yoshida T, Jena N, Qi X, Zhang J, Van Etten R a, et al. Loss of Ikaros DNA-binding function con-
fers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia. Nat
Immunol. 2014; 15: 294–304. https://doi.org/10.1038/ni.2821 PMID: 24509510
15. Schwickert TA, Tagoh H, Gu¨ltekin S, Dakic A, Axelsson E, Minnich M, et al. Stage-specific control of
early B cell development by the transcription factor Ikaros. Nat Immunol. 2014; 15: 283–93. https://doi.
org/10.1038/ni.2828 PMID: 24509509
16. Mullighan CG, Miller CB, Radtke I, Phillips L a, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukae-
mia is characterized by the deletion of Ikaros. Nature. 2008; 453: 110–4. https://doi.org/10.1038/
nature06866 PMID: 18408710
17. Mullighan CG, Xiaoping Su PD, Jinghui Zhang PD, Ina Radtke PD, Letha A.A. Phillips BS, Christopher
B. Miller BS, et al. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia. N Engl J Med.
2009; 360: 470–480. https://doi.org/10.1056/NEJMoa0808253 PMID: 19129520
18. Liang Z, Brown KE, Carroll T, Taylor B, Vidal IF, Hendrich B, et al. A high-resolution map of transcrip-
tional repression. Elife. 2017; 6: 1–24. https://doi.org/10.7554/eLife.22767 PMID: 28318487
19. Law CW, Chen Y, Shi W, Smyth GK. Voom: precision weights unlock linear model analysis tools for
RNA-seq read counts. Genome Biol. 2014; 15: R29. https://doi.org/10.1186/gb-2014-15-2-r29 PMID:
24485249
20. Conesa A, Nueda MJJ, Ferrer A, Talo´n M. maSigPro: a method to identify significantly differential
expression profiles in time-course microarray experiments. Bioinformatics. 2006; 22: 1096–102. https://
doi.org/10.1093/bioinformatics/btl056 PMID: 16481333
21. Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of
cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. Nature Pub-
lishing Group; 2014; 32: 381–6. https://doi.org/10.1038/nbt.2859 PMID: 24658644
22. Fraley C, Raftery AE. Enhanced Model-Based Clustering, Density Estimation, and Discriminant
Analysis Software: MCLUST. J Classif. 2003; 20: 263–286. https://doi.org/10.1007/s00357-003-
0015-3
23. Vitanza NA, Zaky W, Blum R, Meyer JA, Wang J, Bhatla T, et al. Prognosis in children with rhabdomyo-
sarcoma: A report of the intergroup rhabdomyosarcoma studies I and II. Pediatr Blood Cancer. 2014;
61: 1779–1785.
24. Iacobucci I, Iraci N, Messina M, Lonetti A, Chiaretti S, Valli E, et al. IKAROS deletions dictate a unique
gene expression signature in patients with adult B-cell acute lymphoblastic Leukemia. PLoS ONE.
2012; 7. https://doi.org/10.1371/journal.pone.0040934 PMID: 22848414
25. Churchman ML, Mullighan CG. Ikaros: exploiting and targeting the hematopoietic stem cell niche in B-
progenitor acute lymphoblastic leukemia. Exp Hematol. ISEH—International Society for Experimental
Hematology; 2016; 46: 1–8. https://doi.org/10.1016/j.exphem.2016.11.002 PMID: 27865806
26. Churchman ML, Low J, Qu C, Paietta EM, Kasper LH, Chang Y, et al. Efficacy of Retinoids in IKZF1-
Mutated BCR-ABL1 Acute Lymphoblastic Leukemia. Cancer Cell. Elsevier Inc.; 2015; 28: 343–356.
https://doi.org/10.1016/j.ccell.2015.07.016 PMID: 26321221
27. Churchman ML, Evans K, Richmond J, Robbins A, Jones L, Shapiro IM, et al. Synergism of FAK and
tyrosine kinase inhibition in Ph+ B-ALL. JCI Insight. 2016; 1: 1–13. https://doi.org/10.1172/jci.insight.
86082 PMID: 27123491
28. Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, et al.
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide
classification study. Lancet Oncol. 2009; 10: 125–134. https://doi.org/10.1016/S1470-2045(08)70339-5
PMID: 19138562
29. Meixlsperger S, Ko¨hler F, Wossning T, Reppel M, Mu¨schen M, Jumaa H. Conventional Light Chains
Inhibit the Autonomous Signaling Capacity of the B Cell Receptor. Immunity. 2007; 26: 323–333.
https://doi.org/10.1016/j.immuni.2007.01.012 PMID: 17331747
30. Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, et al. The Transcription Factor Myc Con-
trols Metabolic Reprogramming upon T Lymphocyte Activation. Immunity. Elsevier Inc.; 2011; 35: 871–
882. https://doi.org/10.1016/j.immuni.2011.09.021 PMID: 22195744
31. O’Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immu-
nol. 2016; 16: 553–65. https://doi.org/10.1038/nri.2016.70 PMID: 27396447
32. Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, et al. A Validated Regulatory Network for
Th17 Cell Specification. Cell. Elsevier Inc.; 2012; 151: 1–15. https://doi.org/10.1016/j.cell.2012.09.016
PMID: 23021777
33. Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, Awasthi A, et al. Dynamic regulatory network con-
trolling TH17 cell differentiation. Nature. Nature Publishing Group; 2013; 496: 461–8. https://doi.org/10.
1038/nature11981 PMID: 23467089
Feedforward regulation of Myc
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006506 April 12, 2019 26 / 28
34. Tanaka S, Suto A, Iwamoto T, Kashiwakuma D, Kagami S, Suzuki K, et al. Sox5 and c-Maf coopera-
tively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3. J Exp Med.
2014; 211: 1857–1874. https://doi.org/10.1084/jem.20130791 PMID: 25073789
35. Dang E V., Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of Th17/Treg balance by hyp-
oxia-inducible factor 1. Cell. Elsevier Inc.; 2011; 146: 772–784. https://doi.org/10.1016/j.cell.2011.07.
033 PMID: 21871655
36. Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1α–dependent glycolytic pathway
orchestrates a metabolic checkpoint for the differentiation of Th17 and Treg cells. J Exp Med. 2011;
208: 1367–1376. https://doi.org/10.1084/jem.20110278 PMID: 21708926
37. Strino F, Lappe M. Identifying peaks in *-seq data using shape information. BMC Bioinformatics. 2016;
17: S206. https://doi.org/10.1186/s12859-016-1042-5 PMID: 27295177
38. Furio´-Tarı´ P, Conesa A, Tarazona S. RGmatch: matching genomic regions to proximal genes in omics
data integration. BMC Bioinformatics. BMC Bioinformatics; 2016; 17: 1–10.
39. Fistonich C, Zehentmeier S, Bednarski JJ, Miao R, Schjerven H, Sleckman BP, et al. Cell circuits
between B cell progenitors and IL-7+ mesenchymal progenitor cells control B cell development. J Exp
Med. 2018; 215: jem.20180778. https://doi.org/10.1084/jem.20180778 PMID: 30158115
40. Mansson R, Welinder E, Ahsberg J, Lin YC, Benner C, Glass CK, et al. Positive intergenic feedback cir-
cuitry, involving EBF1 and FOXO1, orchestrates B-cell fate. Proc Natl Acad Sci. National Academy of
Sciences; 2012; 109: 21028–21033. https://doi.org/10.1073/pnas.1211427109 PMID: 23213261
41. Bhatt DM, Pandya-Jones A, Tong AJ, Barozzi I, Lissner MM, Natoli G, et al. Transcript dynamics of
proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell. 2012; 150:
279–290. https://doi.org/10.1016/j.cell.2012.05.043 PMID: 22817891
42. Ma S, Pathak S, Mandal M, Trinh L, Clark MR, Lu R. Ikaros and Aiolos Inhibit Pre-B-Cell Proliferation by
Directly Suppressing c-Myc Expression. Mol Cell Biol. 2010; 30: 4149–4158. https://doi.org/10.1128/
MCB.00224-10 PMID: 20566697
43. Kryuchkova-Mostacci N, Robinson-Rechavi M. Tissue-Specificity of Gene Expression Diverges Slowly
between Orthologs, and Rapidly between Paralogs. PLoS Comput Biol 2016; 12: 1–13. https://doi.org/
10.1371/journal.pcbi.1005274 PMID: 28030541
44. Kress TR, Sabò A, Amati B. MYC: connecting selective transcriptional control to global RNA production.
Nat Rev Cancer. Nature Publishing Group; 2015; 15: 593–607. https://doi.org/10.1038/nrc3984 PMID:
26383138
45. Terranova R, Pereira CF, Du Roure C, Merkenschlager M, Fisher AG. Acquisition and extinction of
gene expression programs are separable events in heterokaryon reprogramming. J Cell Sci. 2006; 119:
2065–72. https://doi.org/10.1242/jcs.02945 PMID: 16638804
46. Treutlein B, Lee QY, Camp JG, Mall M, Koh W, Shariati SAM, et al. Dissecting direct reprogramming
from fibroblast to neuron using single-cell RNA-seq. Nature. Nature Publishing Group; 2016; 534: 391–
5. https://doi.org/10.1038/nature18323 PMID: 27281220
47. Chronis C, Fiziev P, Papp B, Butz S, Bonora G, Sabri S, et al. Cooperative Binding of Transcription Fac-
tors Orchestrates Reprogramming. Cell. Elsevier; 2017; 168: 1–18. https://doi.org/10.1016/j.cell.2016.
12.016 PMID: 28111071
48. Wang Y-H, Israelsen WJ, Lee D, Yu VWC, Jeanson NT, Clish CB, et al. Cell-State-Specific Metabolic
Dependency in Hematopoiesis and Leukemogenesis. Cell. Elsevier Inc.; 2014; 158: 1309–1323.
https://doi.org/10.1016/j.cell.2014.07.048 PMID: 25215489
49. Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich MF, Lim R, et al. FOXO1 couples metabolic activity
and growth state in the vascular endothelium. Nature. Nature Publishing Group; 2016; 529: 1–18.
https://doi.org/10.1038/nature16498 PMID: 26735015
50. Conesa A, Madrigal P, Tarazona S, Gomez-Cabrero D, Cervera A, McPherson A, et al. A survey of
best practices for RNA-seq data analysis. Genome Biol. 2016; 17: 13. https://doi.org/10.1186/s13059-
016-0881-8 PMID: 26813401
51. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set
enrichment for pathway analysis. BMC Bioinformatics. 2009; 10: 161. https://doi.org/10.1186/1471-
2105-10-161 PMID: 19473525
52. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette M a, et al. Gene set enrichment
analysis: A knowledge-based approach for interpreting genome-wide. PNAS. 2005; 102: 15545–15550.
https://doi.org/10.1073/pnas.0506580102 PMID: 16199517
53. Bares V, Ge X. gskb: Gene Set data for pathway analysis in mouse. In: R package version 1.6.1. 2015.
54. Bungaro S, Dell’Orto MC, Zangrando A, Basso D, Gorletta T, Nigro L Lo, et al. Integration of Genomic
and Gene Expression Data of Childhood ALLWithout Known Aberrations Identifies Subgroups with
Feedforward regulation of Myc
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006506 April 12, 2019 27 / 28
Specific Genetic Hallmarks. Genes Chromosomes Cancer. 2009; 48: 22–38. https://doi.org/10.1002/
gcc.20616 PMID: 18803328
55. Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, et al. Identification of novel
cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression
profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and out-
come Identification of nov. Blood. 2010; 116: 4874–4884. https://doi.org/10.1182/blood-2009-08-
239681 PMID: 20699438
56. Van Der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal S V., Russell LJ, et al. Inde-
pendent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expres-
sion, in children with B-cell precursor ALL. Blood. 2013; 122: 2622–2629. https://doi.org/10.1182/blood-
2012-10-462358 PMID: 23974192
57. Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang Y-L, Pei D, et al. Targetable kinase-activating
lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014; 371: 1005–15. https://doi.org/10.
1056/NEJMoa1403088 PMID: 25207766
58. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects
and other unwanted variation in high-throughput experiments. Bioinformatics. 2012; 28: 882–3. https://
doi.org/10.1093/bioinformatics/bts034 PMID: 22257669
59. Michaud J, Simpson KM, Escher R, Buchet-Poyau K, Beissbarth T, Carmichael C, et al. Integrative
analysis of RUNX1 downstream pathways and target genes. BMC Genomics. 2008; 9: 363. https://doi.
org/10.1186/1471-2164-9-363 PMID: 18671852
60. Revilla-I-Domingo R, Bilic I, Vilagos B, Tagoh H, Ebert A, Tamir IM, et al. The B-cell identity factor Pax5
regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J. Nature Pub-
lishing Group; 2012; 31: 3130–46. https://doi.org/10.1038/emboj.2012.155 PMID: 22669466
61. Niebuhr B, Kriebitzsch N, Fischer M, Behrens K, Gunther T, Alawi M, et al. Runx1 is essential at two
stages of early murine B-cell development Birte. Blood. 2013; 122: 413–423. https://doi.org/10.1182/
blood-2013-01-480244 PMID: 23704093
62. Ecker JR, Bickmore WA, Barroso I, Pritchard JK, Gilad Y, Segal E. ENCODE explained. Nature. 2012;
489: 52–55. https://doi.org/10.1038/489052a PMID: 22955614
63. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9: 357–360.
https://doi.org/10.1038/nmeth.1923 PMID: 22388286
64. Piper J, Elze MC, Cauchy P, Cockerill PN, Bonifer C, Ott S. Wellington: A novel method for the accurate
identification of digital genomic footprints from DNase-seq data. Nucleic Acids Res. 2013; 41. https://
doi.org/10.1093/nar/gkt850 PMID: 24071585
65. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of tran-
scriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013; 14: R36.
https://doi.org/10.1186/gb-2013-14-4-r36 PMID: 23618408
66. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expres-
sion analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. Nature Publishing Group;
2012; 7: 562–78. https://doi.org/10.1038/nprot.2012.016 PMID: 22383036
67. Witkowski MT, Hu Y, Roberts KG, Boer JM, Mckenzie MD, Liu GJ, Le Grice OD, Tremblay CS, Ghisi M,
Willson TA, Horstmann MA, Aifantis I, Cimmino L, Frietze S, Den Boer ML, Mullighan CG, Smyth GK,
Dickins RA. Conserved Ikaros-regulated genes associated with B-progenitor acute lymphoblastic leuke-
mia outcome. J Exp Med. 2017; 214:773–791. https://doi.org/10.1084/jem.20160048 PMID: 28190000
68. Schjerven H, Ayongaba EF, Aghajanirefah A, Mclaughlin J, Cheng D, Geng H, Boyd JR, Eggesbø LM,
Lindeman I, Heath JL, Park E, Witte ON, Smale ST, Frietze S, Mu¨schen M. Genetic analysis of Ikaros
target genes and tumor suppressor function in BCR-ABL1 + pre–B ALL. J. Exp. Med. 2017; 214: 793–
814. https://doi.org/10.1084/jem.20160049 PMID: 28190001
69. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdo´ttir H, Tamayo P, Mesirov JP. Molecular signa-
tures database (MSigDB) 3.0. Bioinformatics 2011; 27: 1739–1740 https://doi.org/10.1093/
bioinformatics/btr260 PMID: 21546393
70. Lugthart S, Cheok MH, Den Boer ML, Yang W, Holleman A, Cheng C, Pui CH, Relling M V., Janka-
Schaub GE, Pieters R, Evans WE. Identification of genes associated with chemotherapy crossresis-
tance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 2005; 7: 375–
386 https://doi.org/10.1016/j.ccr.2005.03.002 PMID: 15837626
Feedforward regulation of Myc
PLOS Biology | https://doi.org/10.1371/journal.pbio.2006506 April 12, 2019 28 / 28
